PDS Biotechnology Corporation (PDSB) earnings
PDSB earnings moved a median of +0.26% by the close. Quarterly and annual PDSB reports and results, each read against the price at its own news timestamp. Back to the PDSB overview →
26 measured PDSB earnings events.
Where these PDSB earnings landedvs 25 measured PDSB earnings reactions
| Middle 50% of PDSB earnings reactions | -3.42% to +2.27% |
|---|---|
| Median reaction (to close) | +0.26% |
| Measured reactions | 25 |
Point-in-time · zero look-ahead
Half of the 25 PDSB earnings events with a measured close landed between -3.42% and +2.27%; 52% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PDS Biotechnology Corp For: Jun 30 | SEC filing · Form 10-Q | +1.04% | +0.26% | |
| PDS Biotech Reports Second Quarter 2026 Financial Results | Press release | -4.13% | -3.64% | |
| Form 10-Q PDS Biotechnology Corp For: Mar 31 | SEC filing · Form 10-Q | -2.13% | -4.29% | |
| PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update | Press release | +0.90% | +19.82% | |
| Form 10-K/A PDS Biotechnology Corp For: Dec 31 | SEC filing · Form 10-K | -5.41% | -13.49% | |
| Form 10-K PDS Biotechnology Corp For: Dec 31 | SEC filing · Form 10-K | -4.54% | +12.04% | |
| PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update | Press release | -5.30% | — | |
| PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results | Press release | +1.05% | -3.42% | |
| Form 10-Q PDS Biotechnology Corp For: Jun 30 | SEC filing · Form 10-Q | +0.03% | +3.45% | |
| PDS Biotech Reports Second Quarter 2025 Financial Results and Provides Clinical Programs Update | Press release | +4.75% | -7.94% | |
| PDS Biotech Announces Conference Call and Webcast for Second Quarter 2025 Financial Results | Press release | -0.89% | -1.77% | |
| Form 10-Q PDS Biotechnology Corp For: Mar 31 | SEC filing · Form 10-Q | -0.76% | +2.27% | |
| PDS Biotech Reports First Quarter 2025 Financial Results and Provides Clinical Programs and Corporate Update | Press release | +0.76% | -0.76% | |
| PDS Biotech Announces Conference Call and Webcast for First Quarter 2025 Financial Results | Press release | +0.43% | -0.85% | |
| Form 10-K PDS Biotechnology Corp For: Dec 31 | SEC filing · Form 10-K | +3.39% | +6.78% | |
| Form 10-Q PDS Biotechnology Corp For: Sep 30 | SEC filing · Form 10-Q | -2.40% | -8.22% | |
| PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results | Press release | -20.00% | +2.27% | |
| Form 10-Q PDS Biotechnology Corp For: Jun 30 | SEC filing · Form 10-Q | +2.32% | +0.67% | |
| PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results | Press release | -0.98% | -0.33% | |
| Form 10-Q PDS Biotechnology Corp For: Mar 31 | SEC filing · Form 10-Q | -1.99% | +0.28% | |
| PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results | Press release | -2.69% | -5.91% | |
| PDS Biotech to Announce First Quarter 2024 Financial Results on May 15, 2024 | Press release | -1.06% | +0.67% | |
| Form 10-K PDS Biotechnology Corp For: Dec 31 | SEC filing · Form 10-K | -2.36% | +0.00% | |
| Form 10-Q PDS Biotechnology Corp For: Sep 30 | SEC filing · Form 10-Q | -2.35% | +2.43% | |
| PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | +3.13% | +11.25% | |
| PDS Biotechnology Announces Conference Call and Webcast for Third Quarter 2023 Financial Results | Press release | +0.00% | +0.75% |
Keep exploring
More PDSB: analyst actions → · SEC filings → · PDSB overview →